Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540254 · ClinicalTrials.gov registry record · Phase 1
Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
A Phase 1 study of Chronic Fatigue Syndrome and Behavioral Therapy Targeted to Sleep Problems, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00540254: Completed Phase 1 study of Chronic Fatigue Syndrome and Behavioral Therapy Targeted to Sleep Problems, sponsored by Duke University.
NCT00540254 is a Phase 1 study of Chronic Fatigue Syndrome and Behavioral Therapy Targeted to Sleep Problems that has completed, run by Duke University. The registered enrollment target is 24 participants, below the 7,246-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00540254, a Phase 1 study of Chronic Fatigue Syndrome and Behavioral Therapy Targeted to Sleep Problems, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine how best to manage the sleep problems of people with Chronic Fatigue Syndrome. This study is being conducted to determine how improvements in sleep affect other Chronic Fatigue symptoms including pain, fatigue, and mood as well as a person's sense of general well-being.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- OTHER Usual Care for Chronic Fatigue Syndrome (Active Control Group)
Study Locations (1)
North Carolina
- Duke University Medical Center - Insomnia and Sleep Disorders Lab - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-07 |
| Phase | Phase 1 |
What the finished NCT00540254 record still lists
NCT00540254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 7,246-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT00540254 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00540254 about?
NCT00540254 is a clinical study titled "Behavioral Insomnia Therapy With Chronic Fatigue Syndrome". The purpose of this study is to determine how best to manage the sleep problems of people with Chronic Fatigue Syndrome. This study is being conducted to determine how improvements in sleep affect other Chronic Fatigue symptoms including pain, fatigue, and mood as well as a person's sense of general...
What is the current status of trial NCT00540254?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2007-09. Estimated completion is 2010-07.
What conditions does trial NCT00540254 study?
This clinical trial studies the following conditions: Chronic Fatigue Syndrome, Behavioral Therapy Targeted to Sleep Problems.
What interventions are being tested in trial NCT00540254?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Usual Care for Chronic Fatigue Syndrome (Active Control Group) (OTHER).
Who is sponsoring clinical trial NCT00540254?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00540254 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Fatigue Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00540254's enrollment target sits among peer trials
24 11th of 14 higher than 4 of 14 other Chronic Fatigue Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Fatigue Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
RECRUITING · Phase 1
-
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
RECRUITING · Phase 2
-
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
RECRUITING · NA
-
tVNS in Long COVID-19
RECRUITING · NA
-
The Long COVID-19 Wearable Device Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia